Literature DB >> 15864628

Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis.

Thorsten Okulla1, Wolfram S Kunz, Thomas Klockgether, Rolf Schröder, Cornelia Kornblum.   

Abstract

PURPOSE: To highlight the diagnostic relevance of mitochondrial DNA (mtDNA) mutation analysis in acquired juvenile unilateral upper eyelid ptosis.
METHODS: A 13-year-old boy presented with acquired, slowly progressive unilateral ptosis. We performed ophthalmological and neurological examinations, laboratory testing, skeletal muscle biopsy including histological and histochemical investigations, biochemical analysis of respiratory chain enzymes in skeletal muscle homogenate and molecular genetic testing of skeletal muscle DNA.
RESULTS: Though clinical, laboratory, histological and biochemical analyses did not reveal any hints suggesting a mitochondrial cytopathy, molecular genetic testing by Southern blot analysis of total DNA from skeletal muscle tissue showed a 5.8 kb mtDNA deletion thus proving the diagnosis of mitochondrial chronic progressive external ophthalmoplegia (CPEO).
CONCLUSIONS: In patients with unexplained acquired juvenile unilateral ptosis, an underlying mitochondrial cytopathy should be considered even in cases of inconspicuous ancillary examinations comprising skeletal muscle histology and biochemistry. To establish the diagnosis, molecular genetic testing of DNA derived from skeletal muscle tissue is essential in those patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15864628     DOI: 10.1007/s00417-004-1000-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  ANT1, Twinkle, POLG, and TP: new genes open our eyes to ophthalmoplegia.

Authors:  M Hirano; S DiMauro
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

Review 2.  Mitochondrial DNA mutations in human disease.

Authors:  S DiMauro; E A Schon
Journal:  Am J Med Genet       Date:  2001

Review 3.  Diseases of oxidative phosphorylation due to mtDNA mutations.

Authors:  S DiMauro; A L Andreu; O Musumeci; E Bonilla
Journal:  Semin Neurol       Date:  2001-09       Impact factor: 3.420

Review 4.  Clinical features, investigation, and management of patients with defects of mitochondrial DNA.

Authors:  P F Chinnery; D M Turnbull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

5.  New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle.

Authors:  R Schröder; S Vielhaber; F R Wiedemann; C Kornblum; A Papassotiropoulos; P Broich; S Zierz; C E Elger; H Reichmann; P Seibel; T Klockgether; W S Kunz
Journal:  J Neuropathol Exp Neurol       Date:  2000-05       Impact factor: 3.685

Review 6.  Mitochondrial disorders: clinical and genetic features.

Authors:  D K Simon; D R Johns
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

Review 7.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

Review 8.  Neuro-ophthalmology of mitochondrial diseases.

Authors:  Valérie Biousse; Nancy J Newman
Journal:  Curr Opin Neurol       Date:  2003-02       Impact factor: 5.710

  8 in total
  2 in total

1.  [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].

Authors:  B Wabbels; N Ali; W S Kunz; P Roggenkämper; C Kornblum
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

2.  Electron microscopic findings in levator muscle biopsies of patients with isolated congenital or acquired ptosis.

Authors:  Bettina Wabbels; Josef A Schroeder; Beate Voll; Heiko Siegmund; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-24       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.